Editorial Commentary
The heterogeneity in oligoprogression and stereotactic body radiation therapy
Translational Cancer Research
2025;
14
(1)
:1-6
.
(31 January 2025)
Small cell lung carcinoma with YAP1 expression and SMARCA4-deficient undifferentiated tumors
Translational Cancer Research
2025;
14
(1)
:7-10
.
(31 January 2025)
Navigating restriction from interstitial lung disease (ILD) with stereotactic ablative radiotherapy (SABR) in early-stage non-small cell lung cancer: soaring beyond the current treatment paradigm
Translational Cancer Research
2025;
14
(1)
:11-15
.
(31 January 2025)
How to select between osimertinib or afatinib in P-loop and αC-helix compressing (G719X, S768I) or classical-like (L861Q) EGFR mutations: what preclinical models and clinical data have taught us in the early 2020s
Translational Cancer Research
2025;
14
(1)
:16-23
.
(31 January 2025)
On the precipice of a new generation of biomarkers for immunotherapy in small cell lung cancer
Translational Cancer Research
2025;
14
(1)
:24-28
.
(31 January 2025)
Optimizing immunotherapy for lung cancer: integrating genetic alterations and the tumor mutational burden to refine patient selection
Translational Cancer Research
2025;
14
(1)
:29-32
.
(31 January 2025)
Original Article
Prognostic development and validation of a prediction model based on major histocompatibility complex-related differentially expressed genes in stomach adenocarcinoma
Translational Cancer Research
2025;
14
(1)
:33-61
.
(31 January 2025)
Assessing mortality risk and causes in extramammary Paget’s disease: insights from a population-based study
Translational Cancer Research
2025;
14
(1)
:62-70
.
(31 January 2025)
Testosterone and colorectal cancer: a bidirectional Mendelian randomization study
Translational Cancer Research
2025;
14
(1)
:71-77
.
(31 January 2025)
METTL3 stabilizes SERPINE2 via the m6A modification to drive the malignant progression of gastric signet ring cell carcinoma
Translational Cancer Research
2025;
14
(1)
:78-92
.
(31 January 2025)
A new risk algorithm combining D-dimer and HE4 differentiates borderline tumor from patients with ovarian tumor
Translational Cancer Research
2025;
14
(1)
:93-101
.
(31 January 2025)
Analysis of the quality of vulvar cancer-related videos on YouTube
Translational Cancer Research
2025;
14
(1)
:102-111
.
(31 January 2025)
Mitochondrial single-stranded DNA binding protein 1 (SSBP1) high expression as a potential biomarker and association with poor prognosis in hepatocellular carcinoma (HCC)
Translational Cancer Research
2025;
14
(1)
:112-128
.
(31 January 2025)
Cuproptosis-related genes signature could predict prognosis and the response of immunotherapy in cervical cancer
Translational Cancer Research
2025;
14
(1)
:129-140
.
(31 January 2025)
Development of a nomogram predicting perineural invasion risk and assessment of the prognostic value of perineural invasion in colon cancer: a population study based on the Surveillance, Epidemiology, and End Results database
Translational Cancer Research
2025;
14
(1)
:141-158
.
(31 January 2025)
Development and validation of a prognostic model based on disulfidptosis-related ferroptosis genes: DRD4 and SLC2A3 as biomarkers for predicting prognosis in colon cancer
Translational Cancer Research
2025;
14
(1)
:159-178
.
(31 January 2025)
A 5-lncRNA signature predicts clinical prognosis and demonstrates a different mRNA expression in adult soft tissue sarcoma
Translational Cancer Research
2025;
14
(1)
:179-196
.
(31 January 2025)
By integrating single-cell RNA sequencing and bulk RNA sequencing, plasma cells signature and tertiary lymphoid structures were verified to contribute to outcome in lung adenocarcinoma
Translational Cancer Research
2025;
14
(1)
:197-211
.
(31 January 2025)
Single nucleotide polymorphism and promoter methylation analysis of protein tyrosine phosphatase 1B in patients with myeloproliferative neoplasms
Translational Cancer Research
2025;
14
(1)
:212-224
.
(31 January 2025)
Establishment and validation of predictive models by mutational and transcriptional factors for the prognosis of stage IV colorectal cancer patients with liver metastasis who undergo palliative surgery on primary tumors
Translational Cancer Research
2025;
14
(1)
:225-239
.
(31 January 2025)
Establishment and validation of a prognostic prediction model for glioma based on key genes and clinical factors
Translational Cancer Research
2025;
14
(1)
:240-253
.
(31 January 2025)
Construction and validation of a prognostic signature using WGCNA-identified key genes in osteosarcoma for treatment evaluation
Translational Cancer Research
2025;
14
(1)
:254-271
.
(31 January 2025)
Association of systemic inflammatory response index with all-cause and malignant neoplasm mortality in patients with gastrointestinal disease
Translational Cancer Research
2025;
14
(1)
:272-285
.
(31 January 2025)
Emodin reverses sorafenib resistance in hepatocellular carcinoma by inhibiting epithelial-mesenchymal transition via the Akt signaling pathway
Translational Cancer Research
2025;
14
(1)
:286-295
.
(31 January 2025)
Diagnostic value of a lactylation-related gene signature in hepatocellular carcinoma
Translational Cancer Research
2025;
14
(1)
:296-312
.
(31 January 2025)
Association between surrogate indices of fatty liver and the risk of colorectal cancer: a cross-sectional United States study
Translational Cancer Research
2025;
14
(1)
:313-326
.
(31 January 2025)
Immune checkpoint inhibitors plus paclitaxel-based chemotherapy vs. oxaliplatin-based therapy as first-line treatment for patients with HER2-negative unresectable or metastatic gastric/gastroesophageal junction cancer: results of a multicenter retrospective study
Translational Cancer Research
2025;
14
(1)
:327-339
.
(31 January 2025)
Deciphering the prognostic potential of a necroptosis-related gene signature in head and neck squamous cell carcinoma: a bioinformatic analysis
Translational Cancer Research
2025;
14
(1)
:340-353
.
(31 January 2025)
EPB41L4A-AS1 regulates cervical cancer by proliferative cells: mendelian randomization and single-cell transcriptomics analyses
Translational Cancer Research
2025;
14
(1)
:354-370
.
(31 January 2025)
Impact of systemic immune-inflammation index and its evaluation of optimal threshold in patients with limited-stage small cell lung cancer: a retrospective study based on 572 cases
Translational Cancer Research
2025;
14
(1)
:371-382
.
(31 January 2025)
Comparative efficacy of transarterial chemoembolization with and without PD-1 inhibitor in the treatment of unresectable liver cancer and construction and validation of prognostic models
Translational Cancer Research
2025;
14
(1)
:383-403
.
(31 January 2025)
Establishing a prognostic scoring system and exploring prognostic value of examined lymph node numbers for stage I non-small cell lung cancer: a retrospective study of Surveillance, Epidemiology, and End Results (SEER) database and a Chinese cohort
Translational Cancer Research
2025;
14
(1)
:404-423
.
(31 January 2025)
Level and clinical significance of serum CXC chemokine ligand 13 in patients with hepatocellular carcinoma
Translational Cancer Research
2025;
14
(1)
:424-433
.
(31 January 2025)
Single-cell programmed cell death regulator patterns guide intercellular communication of cancer-associated fibroblasts that contribute to colorectal cancer progression
Translational Cancer Research
2025;
14
(1)
:434-460
.
(31 January 2025)
Relationship between survival outcomes in patients with colorectal liver metastasis undergoing hepatectomy and significance of fibrotic markers for liver injury assessment
Translational Cancer Research
2025;
14
(1)
:461-472
.
(31 January 2025)
Association between serum urate levels, gout and breast cancer: observational and Mendelian randomization analyses
Translational Cancer Research
2025;
14
(1)
:473-485
.
(31 January 2025)
Potential therapeutic targets for colorectal cancer and its subsites: evidence from the proteome-wide Mendelian randomization analyses
Translational Cancer Research
2025;
14
(1)
:486-496
.
(31 January 2025)
Oxidative phosphorylation-related genes for prognosis and tumor microenvironment in breast cancer
Translational Cancer Research
2025;
14
(1)
:497-511
.
(31 January 2025)
Unlocking the future: mitochondrial genes and neural networks in predicting ovarian cancer prognosis and immunotherapy response
Translational Cancer Research
2025;
14
(1)
:512-521
.
(31 January 2025)
ARNTL2: a key player in promoting tumor aggressiveness in papillary thyroid cancer
Translational Cancer Research
2025;
14
(1)
:522-534
.
(31 January 2025)
Adenanthin inhibits pancreatic cancer proliferation by regulation of H2O2/ROS
Translational Cancer Research
2025;
14
(1)
:535-544
.
(31 January 2025)
A predictive nomogram for predicting liver metastasis in early-onset colon cancer: a population-based study
Translational Cancer Research
2025;
14
(1)
:545-553
.
(31 January 2025)
Based on network pharmacology and experimental validation, berberine can inhibit the progression of gastric cancer by modulating oxidative stress
Translational Cancer Research
2025;
14
(1)
:554-568
.
(31 January 2025)
Analysis and exploration of regulatory mechanisms and potential prognostic biomarkers in squamous cell carcinoma of the lung by expression profiling
Translational Cancer Research
2025;
14
(1)
:569-583
.
(31 January 2025)
LncRNA ZEB1-AS1 promotes the proliferation and migration of non-small cell lung cancer by activating epithelial-mesenchymal transition with STAT3
Translational Cancer Research
2025;
14
(1)
:584-594
.
(31 January 2025)
FTO-mediated m6A demethylation of SERPINE1 mRNA promotes tumor progression in hypopharyngeal squamous cell carcinoma
Translational Cancer Research
2025;
14
(1)
:595-612
.
(31 January 2025)
Identification and validation of LINC02381 as a biomarker associated with lymph node metastasis in esophageal squamous cell carcinoma
Translational Cancer Research
2025;
14
(1)
:613-625
.
(31 January 2025)
Exploration of key pathogenic mechanisms and potential intervention targets of the traditional Chinese medicine Coptis chinensis in the treatment of cervical cancer based on network pharmacology and molecular docking techniques
Translational Cancer Research
2025;
14
(1)
:626-639
.
(31 January 2025)
A diagnostic test of two-dimensional ultrasonic feature extraction based on artificial intelligence combined with blood flow Adler classification and contrast-enhanced ultrasound for predicting HER-2-positive breast cancer
Translational Cancer Research
2025;
14
(1)
:640-650
.
(31 January 2025)
Surgical Technique
Nerve sparing excision of gastrohepatic ligament lesion as part of cytoreductive surgical management of advanced ovarian malignancy
Translational Cancer Research
2025;
14
(1)
:651-655
.
(31 January 2025)
Erratum
Erratum: miR-137 represses migration and cell motility by targeting COX-2 in non-small cell lung cancer
Translational Cancer Research
2025;
14
(1)
:656-657
.
(31 January 2025)
Retraction
Retraction: MicroRNA-153-3p sensitizes melanoma cells to dacarbazine by suppressing ATG5-mediated autophagy and apoptosis
Translational Cancer Research
2025;
14
(1)
:658-659
.
(31 January 2025)
